Raymond James Financial Services Advisors, Inc. Relay Therapeutics, Inc. Transaction History
Raymond James Financial Services Advisors, Inc.
- $69.1 Billion
- Q2 2024
A detailed history of Raymond James Financial Services Advisors, Inc. transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Raymond James Financial Services Advisors, Inc. holds 64,265 shares of RLAY stock, worth $420,293. This represents 0.0% of its overall portfolio holdings.
Number of Shares
64,265
Previous 54,888
17.08%
Holding current value
$420,293
Previous $455,000
7.91%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding RLAY
# of Institutions
183Shares Held
127MCall Options Held
1.7KPut Options Held
18K-
Sb Investment Advisers (Uk) LTD London, X027.9MShares$182 Million1.68% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.7MShares$76.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY10.5MShares$68.9 Million0.0% of portfolio
-
Casdin Capital, LLC New York, NY8.45MShares$55.3 Million4.77% of portfolio
-
Bellevue Group Ag Kuesnacht, V86.38MShares$41.7 Million0.7% of portfolio
About Relay Therapeutics, Inc.
- Ticker RLAY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 120,219,000
- Market Cap $786M
- Description
- Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...